Patient Derived Ex-Vivo Cancer Models in Drug Development, Personalized Medicine, and Radiotherapy

SIMPLE SUMMARY: This review article highlights gaps in the current system of drug development and personalized medicine for cancer therapy. The ex vivo model system using tissue biopsy from patients will advance the development of the predictive disease specific biomarker, drug screening and assessm...

Descripción completa

Detalles Bibliográficos
Autores principales: Zitter, Ryan, Chugh, Rishi Man, Saha, Subhrajit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220792/
https://www.ncbi.nlm.nih.gov/pubmed/35740672
http://dx.doi.org/10.3390/cancers14123006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220792/
https://www.ncbi.nlm.nih.gov/pubmed/35740672
http://dx.doi.org/10.3390/cancers14123006

Ejemplares similares